Profil
Sandy Loreaux is currently the Director at Bryn Pharma LLC.
Prior to this, Ms. Loreaux was the President at Covis Pharma US, Inc. Ms. Loreaux completed their undergraduate degree at Temple University School of Pharmacy.
Postes actifs de Sandy Loreaux
| Sociétés | Poste | Début |
|---|---|---|
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Directeur/Membre du Conseil | 29/11/2022 |
Anciens postes connus de Sandy Loreaux
| Sociétés | Poste | Fin |
|---|---|---|
Covis Pharma Us, Inc.
Covis Pharma Us, Inc. Aerospace & DefenseElectronic Technology The private company is based in King of Prussia, PA. Covis Pharma US, Inc. is a specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening and chronic illnesses in over 50 countries. The company offers a portfolio of branded medications across multiple therapeutic areas including respiratory, allergy, hematology, cardiovascular, and gastroenterology. Covis Pharma supports educational initiatives, investigator-sponsored research, and patient assistance programs to improve access to therapies, and pursues business development through acquisitions, line extensions, and late-stage clinical programs. The CEO of the company is Michael Porter. | President | - |
Formation de Sandy Loreaux
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Temple University School of Pharmacy
Temple University School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
Covis Pharma Us, Inc.
Covis Pharma Us, Inc. Aerospace & DefenseElectronic Technology The private company is based in King of Prussia, PA. Covis Pharma US, Inc. is a specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening and chronic illnesses in over 50 countries. The company offers a portfolio of branded medications across multiple therapeutic areas including respiratory, allergy, hematology, cardiovascular, and gastroenterology. Covis Pharma supports educational initiatives, investigator-sponsored research, and patient assistance programs to improve access to therapies, and pursues business development through acquisitions, line extensions, and late-stage clinical programs. The CEO of the company is Michael Porter. | Electronic Technology |
















